![Michael Tönes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Tönes
Amministratore Delegato presso BC Brandenburg Capital GmbH
Profilo
Mr. Michael Tönes is a Managing Director at BC Brandenburg Capital GmbH.
Mr. Tönes was previously employed as Chairman-Supervisory Board by Combinature BioPharm AG and a Director-Supervisory Board by Capsulution Pharma AG.
Posizioni attive di Michael Tönes
Società | Posizione | Inizio |
---|---|---|
BC Brandenburg Capital GmbH
![]() BC Brandenburg Capital GmbH Investment ManagersFinance BC Brandenburg Capital GmbH (BC GmbH) is a venture capital investment firm and a majority-owned subsidiary of ILB-Investitionsbank des Landes Brandenburg, the promotional bank for the State of Brandenburg in the east of Germany. BC GmbH was established in 2000 and is headquartered in Potsdam near Berlin, with an office in Frankfurt an der Oder, on the German-Polish border. The firm manages a series of venture capital funds, and invests a combination of private and public funds. | Amministratore Delegato | 01/01/2001 |
Precedenti posizioni note di Michael Tönes
Società | Posizione | Fine |
---|---|---|
Combinature BioPharm AG
![]() Combinature BioPharm AG Miscellaneous Commercial ServicesCommercial Services Combinature Biopharm AG discovers and develops drugs. It provides natural compound based clinical development candidates, particularly in the areas of infectious diseases and oncology. It applies its technologies to make improved versions of known natural product pharmaceuticals and to advance such improved drug candidates into pre-clinical and clinical trials. The company was founded in 2000 and is headquartered in Berlin, Germany. | Presidente | 27/08/2008 |
Capsulution Pharma AG
![]() Capsulution Pharma AG Miscellaneous Commercial ServicesCommercial Services Capsulution Pharma AG is a leading nanotechnology enterprise specialized in the customer-specific development of life-science products. As a spin-off of the Max Planck Society, its enterprise is a pioneer in the commercial utilization of the latest research results from the field of nanotechnology. They are opening up new frontiers by applying nanotechnology to the modern challenges of pharmaceutical therapy, medical technology and diagnostics. For this they use the years of expertise its staff and partners can offer as well as its internationally patented technologies for the production of multi-functional nanocapsules and nanocomplexes. Its nanocapsules and complexes are intelligent 'transport containers', so small that around 3 billion fit on the head of a single pin. Special processes allow them to furnish these tiny transport containers with a combination of pharmaceutical, biochemical, electrical, optical and magnetic properties. On this basis they are able to develop solutions that are always innovative and market-oriented, for example for more targeted and more effective drug delivery. Thanks to the right combination of specialized knowledge innovative spirit and reliability, Capsulution has been able to play the multiple roles of initiator, developer and consultant on the way to many a successful product. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Combinature BioPharm AG
![]() Combinature BioPharm AG Miscellaneous Commercial ServicesCommercial Services Combinature Biopharm AG discovers and develops drugs. It provides natural compound based clinical development candidates, particularly in the areas of infectious diseases and oncology. It applies its technologies to make improved versions of known natural product pharmaceuticals and to advance such improved drug candidates into pre-clinical and clinical trials. The company was founded in 2000 and is headquartered in Berlin, Germany. | Commercial Services |
Capsulution Pharma AG
![]() Capsulution Pharma AG Miscellaneous Commercial ServicesCommercial Services Capsulution Pharma AG is a leading nanotechnology enterprise specialized in the customer-specific development of life-science products. As a spin-off of the Max Planck Society, its enterprise is a pioneer in the commercial utilization of the latest research results from the field of nanotechnology. They are opening up new frontiers by applying nanotechnology to the modern challenges of pharmaceutical therapy, medical technology and diagnostics. For this they use the years of expertise its staff and partners can offer as well as its internationally patented technologies for the production of multi-functional nanocapsules and nanocomplexes. Its nanocapsules and complexes are intelligent 'transport containers', so small that around 3 billion fit on the head of a single pin. Special processes allow them to furnish these tiny transport containers with a combination of pharmaceutical, biochemical, electrical, optical and magnetic properties. On this basis they are able to develop solutions that are always innovative and market-oriented, for example for more targeted and more effective drug delivery. Thanks to the right combination of specialized knowledge innovative spirit and reliability, Capsulution has been able to play the multiple roles of initiator, developer and consultant on the way to many a successful product. | Commercial Services |
BC Brandenburg Capital GmbH
![]() BC Brandenburg Capital GmbH Investment ManagersFinance BC Brandenburg Capital GmbH (BC GmbH) is a venture capital investment firm and a majority-owned subsidiary of ILB-Investitionsbank des Landes Brandenburg, the promotional bank for the State of Brandenburg in the east of Germany. BC GmbH was established in 2000 and is headquartered in Potsdam near Berlin, with an office in Frankfurt an der Oder, on the German-Polish border. The firm manages a series of venture capital funds, and invests a combination of private and public funds. | Finance |
- Borsa valori
- Insiders
- Michael Tönes